Organisation paid for research Program year 2025 Source: CMS Open Payments

Desert Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$6,667,301

187 payments

Through program year 2025, Desert Clinical Research, LLC is reported as receiving $6,667,301 in research payments, across 187 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$6,500	1
2024	Research	$2,367,909	86
2023	Research	$4,292,892	100

Breakdown

Who paid Research payments · program years 2023–2025

Moderna TX, Inc. $6,660,801 186 payments
AstraZeneca Pharmaceuticals LP $6,500 1 payment

Studies the money was for Research payments · program years 2023–2025

A Phase 2/3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), in Adults 60 Years of Age $5,475,120 137 payments
A Phase 3, randomized, observerblind, activecontrol study to evaluate the safety, reactogenicity, and immunogenicity of mRNA1083 (SARSCoV2 and influenza) vaccine in healthy adult participants, 50 years of age. $503,203 20 payments
A Phase 3, randomized, stratified, observer-blind, active-controlled study to evaluate the immunogenicity, reactogenicity and safety of mRNA-1010 seasonal influenza vaccine in adults 18 years and older $500,557 25 payments
Observational secondary-use comparative effectiveness cohort study with tokenized clinical trial and real-world data. $181,921 4 payments
a phase 3,global,randomized,modified double blind,placebo controlled,study to evaluate the efficacy,immunogenicity,and safety of IVX A12,a respiratory syncytial virus RSV and human metapneumovirus hMPV virus like particle VLP vaccine in adults 60 years of age and older $6,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.